1Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis [J]. Hepatology,1988,8(5):1151.
2Schrier RW. Body fluid volume regultion in health and disease: a unifying hypothesis [J]. Ann Intern Med, 1990, 113: 155.
4Pizcueta P, Pique JM, Bosch J, et al. Hemodynamic effects of endogenous nitric oxide inhibition in cirrhotic rats [J]. Hepatology,1991,14(4)Pt,2:123.
5Knowles RG, Merrett M, Salter M, et al. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat [J], Biochem J, 1990, 270: 833.
6Guarner C, Soriano G, Such J, et al, Systemic prostacyclin in cirrhotic patients: Relationship with Portal hypertension and changes after intestinal decontamination [J]. Gastroenterology, 1992, 102(1): 303.
7Guarner F, Guarner C, Prieto J, et al. Increased synthesis of systemic prostacyclin in cirrhotic patients [J]. Gastroenterology, 1986,90:687,
8Lin HC, Yang ME, Hou MC, et al. Hyperglucogonemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic value [J], J Gastroenterol Hepatol, 1996, 11 (3): 422.
9Moiler S, Bendtsen F, Schifter S, et al. Relation of calcitonin generalated peptide to systemic va.sodilation and central hypovolaemia in cirrhosis [J], Scand J Gastroentero, 1996, 31 : 928.
10Caramelo C, Fernandez - Gallardo S, Inarrea P, et al. Increased levels of platelet - activating factor in blood from patients with cirrhosisof the liver [J]. Eur J Clin Invest, 1987, 17: 7.
